Spots Global Cancer Trial Database for pathway her2 (4b5) assay
Every month we try and update this database with for pathway her2 (4b5) assay cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer | NCT06253494 | Endometrial Can... Cancer of Endom... Carcinoma of En... Endometrial Car... | AdHER2DC vaccin... Pembrolizumab N-803 Lenvatinib PATHWAY HER2 (4... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) |